Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) (ROSETTA)
Sponsor: Brown University
A PHASE3 clinical study on Urinary Incontinence, Urge, this trial is completed. The trial is conducted by Brown University and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Mar 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brown University
- Duke University
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NICHD Pelvic Floor Disorders Network
- Oregon Health and Science University
- RTI International
- The Cleveland Clinic
- University of Alabama at Birmingham
- University of California, San Diego
- University of New Mexico
- University of Pennsylvania
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .